Head and Neck Cancer Proteomic Advances and Biomarker Achievements

被引：54
|
作者：
Berto Rezende, Taia Maria [1 ]
Freire, Mirna de Souza [1 ]
Franco, Octavio Luiz [1 ]
机构：
[1] Univ Catolica Brasilia, Ctr Prote & Biochem Anal, Brasilia, DF, Brazil
来源：
CANCER | 2010年 / 116卷 / 21期
关键词：
head and neck cancer; proteomics; cancer risk factors; cancer pathogenesis; diagnostic biomarkers; SQUAMOUS-CELL CARCINOMA; EPIDERMAL-GROWTH-FACTOR; 2-DIMENSIONAL GEL-ELECTROPHORESIS; LASER CAPTURE MICRODISSECTION; ORAL EPITHELIAL DYSPLASIA; IMAGING MASS-SPECTROMETRY; UPPER AERODIGESTIVE TRACT; PROTEIN PROFILE ANALYSIS; NASOPHARYNGEAL CARCINOMA; FACTOR RECEPTOR;
D O I：
10.1002/cncr.25245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumors of the head and neck comprise an important neoplasia group, the incidence of which is increasing in many parts of the world. Recent advances in diagnostic and therapeutic techniques for these lesions have yielded novel molecular targets, uncovered signal pathway dominance, and advanced early cancer detection. Proteomics is a powerful tool for investigating the distribution of proteins and small molecules within biological systems through the analysis of different types of samples. The proteomic profiles of different types of cancer have been studied, and this has provided remarkable advances in cancer understanding. This review covers recent advances for head and neck cancer; it encompasses the risk factors, pathogenesis, proteomic tools that can help in understanding cancer, and new proteomic findings in this type of cancer. Cancer 2010;116:4914-25. (C) 2010 American Cancer Society
引用
收藏
页码：4914 / 4925
页数：12
相关论文
共 50 条
  • [1] Protein biomarker discovery for head and neck cancer
    Schaaij-Visser, Tieneke B. M.
    Brakenhoff, Ruud H.
    Leemans, C. Rene
    Heck, Albert J. R.
    Slijper, Monique
    JOURNAL OF PROTEOMICS, 2010, 73 (10) : 1790 - 1803
  • [2] Advances in pharmacotherapy for head and neck cancer
    Kumar, Shikhar
    Noronha, Vanita
    Patil, Vijay
    Joshi, Amit
    Menon, Nandini
    Prabhash, Kumar
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (15) : 2007 - 2018
  • [3] Designing biomarker studies for head and neck cancer
    Kim, Kelly Y.
    McShane, Lisa M.
    Conley, Barbara A.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2014, 36 (07): : 1069 - 1075
  • [4] Recent advances in surgery for head and neck cancer
    de Bree, Remco
    Leemans, Charles Rene
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (03) : 186 - 193
  • [5] Methylation as a biomarker for head and neck cancer
    Arantes, L. M. R. B.
    de Carvalho, A. C.
    Melendez, M. E.
    Carvalho, A. L.
    Goloni-Bertollo, E. M.
    ORAL ONCOLOGY, 2014, 50 (06) : 587 - 592
  • [6] Proteomic Identification of Serum Biomarkers for Head and Neck Cancer Surveillance
    Gourin, Christine G.
    Zhi, Wenbo
    Adam, Bao-Ling
    LARYNGOSCOPE, 2009, 119 (07): : 1291 - 1302
  • [7] Genetic and proteomic biomarkers of head-and-neck cancer: A systematic review
    Kasradze, David
    Juodzbalys, Gintaras
    Guobis, Zygimantas
    Gervickas, Albinas
    Cicciu, Marco
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (03) : 410 - 424
  • [8] Immunotherapy for head and neck cancer: advances and deficiencies
    De Costa, Anna-Maria
    Young, M. Rita I.
    ANTI-CANCER DRUGS, 2011, 22 (07) : 674 - 681
  • [9] Top advances of the year: Head and neck cancer
    Verma, Avanti
    Burtness, Barbara
    CANCER, 2023, 129 (09) : 1308 - 1312
  • [10] DNA Methylation as a Diagnostic, Prognostic, and Predictive Biomarker in Head and Neck Cancer
    Liouta, Galateia
    Adamaki, Maria
    Tsintarakis, Antonis
    Zoumpourlis, Panagiotis
    Liouta, Anastasia
    Agelaki, Sofia
    Zoumpourlis, Vassilis
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
12345